Ramkumar Mandalam
Director/Board Member at CRYOPORT, INC.
Net worth: 576 009 $ as of 2024-05-30
Ramkumar Mandalam active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CRYOPORT, INC. | Director/Board Member | 2014-06-15 | - |
| Independent Dir/Board Member | 2014-06-15 | - | |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Director/Board Member | 2010-10-19 | - |
| Chief Executive Officer | 2004-12-31 | - | |
| President | 2004-12-31 | - | |
Stempeutics Research Pvt. Ltd.
 Stempeutics Research Pvt. Ltd. Pharmaceuticals: MajorHealth Technology Stempeutics Research Pvt. Ltd. is a clinical-stage biotech company based in Bangalore, India. The private company was founded in 2006 by Manipal Education and Medical Group (MEMG) and has since formed strategic alliances with Cipla in 2009 and with Kemwell in 2019. Stempeutics specializes in developing innovative stem cell products through cutting-edge research and clinical applications. Its highly qualified team is dedicated to developing novel cell therapy drugs to address major unmet medical needs with a first-next approach. | Director/Board Member | - | - |
| Citra Bioconsulting, Inc. | Chief Executive Officer | 2020-12-31 | - |
| Founder | 2020-12-31 | - |
Career history of Ramkumar Mandalam
Former positions of Ramkumar Mandalam
| Companies | Position | Start | End |
|---|---|---|---|
| VERICEL CORPORATION | Chief Tech/Sci/R&D Officer | 1993-12-31 | 1999-12-31 |
| Corporate Officer/Principal | 1993-12-31 | 1999-12-31 | |
| GERON CORPORATION | Corporate Officer/Principal | - | - |
Training of Ramkumar Mandalam
| University of Michigan | Doctorate Degree |
Statistics
International
| United States | 7 |
| India | 2 |
Operational
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
| Transportation | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| GERON CORPORATION | Health Technology |
| VERICEL CORPORATION | Health Technology |
| CRYOPORT, INC. | Transportation |
| Private companies | 3 |
|---|---|
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Health Technology |
Stempeutics Research Pvt. Ltd.
Stempeutics Research Pvt. Ltd. Pharmaceuticals: MajorHealth Technology Stempeutics Research Pvt. Ltd. is a clinical-stage biotech company based in Bangalore, India. The private company was founded in 2006 by Manipal Education and Medical Group (MEMG) and has since formed strategic alliances with Cipla in 2009 and with Kemwell in 2019. Stempeutics specializes in developing innovative stem cell products through cutting-edge research and clinical applications. Its highly qualified team is dedicated to developing novel cell therapy drugs to address major unmet medical needs with a first-next approach. | Health Technology |
| Citra Bioconsulting, Inc. |
- Stock Market
- Insiders
- Ramkumar Mandalam
- Experience
